Haruka Shinohara

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2023
Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia.

Ayuna Hattori, Emi Takamatsu-Ichihara, Yoshiki Yamamoto

|May 09, 2019
MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.

Takuya Tsujino, Nobuhiko Sugito, Kohei Taniguchi

|Apr 10, 2019
Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.

Yoshihisa Tokumaru, Toshihiro Tajirika, Nobuhiko Sugito

|Dec 15, 2018
Potent antiproliferative effect of fatty-acid derivative AIC-47 on leukemic mice harboring BCR-ABL mutation.

Haruka Shinohara, Nobuhiko Sugito, Yuki Kuranaga

|Apr 27, 2018
Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression.

Kohei Taniguchi, Nobuhiko Sugito, Haruka Shinohara

Pageof 1